In models of subarachnoid hemorrhage and multiple sclerosis, gene suppression or pharmacological inhibition (glibenclamide) of Abcc8/Sur1 significantly ameliorates neuroinflammation and improves neurological function, with these effects attributed to inhibition of Sur1-Trpm4 channels [36–38]. The gene discussed is ABCC8; the disease is multiple sclerosis.